Results 71 to 80 of about 457 (170)

DRUG THERAPY OF NEUROGENIC BLADDER - THE EFFECTS OF ADMINISTRATION OF TOLPERISONE HYDROCHLORIDE TO PATIENTS WITH DYSSYNERGIA BETWEEN DETRUSOR AND EXTERNAL URETHRAL SPHINCTER - [PDF]

open access: yes, 1975
There are many patients with neurogenic bladder who complain of dyssynergia between detrusor and external urethral sphincter. Intra-abdominal pressure.
福井, 準之助
core  

Fatal tolperisone poisoning: Autopsy and toxicology findings in three suicide cases.

open access: yes, 2011
Tolperisone (Mydocalm(®)) is a centrally acting muscle relaxant with few sedative side effects that is used for the treatment of chronic pain conditions.
Brunel, C.   +3 more
core  

EFFECT OF THE REFLEXOTHERAPY ON THE QUALITY OF LIFE IN PATIENTS WITH CHRONIC TENSION-TYPE HEADACHE

open access: yesКубанский научный медицинский вестник, 2018
Aim. To estimate the effect of reflexotherapy and standard pharmacological therapy on quality of life in patients with chronic tension-type headache (CTTH).Materials and methods.
L. N. BELIMOVA, V. A. BALYAZIN
doaj   +1 more source

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DICLOFENAC AND TOLPERISONE IN TABLET DOSAGE FORM

open access: yes, 2013
Objective: To develop a simple and cost effective reverse phase high performance liquid chromatography method for simultaneous estimation of Diclofenac and Tolperisone in tablet dosage form.
vemula, venkata raveendra babu   +1 more
core  

Multicenter, randomized, double-blind study of the efficacy and safety of prolonged release tolperisone hydrochloride 450 mg (Mydocalm® Long, once daily) and tolperisone hydrochloride 150 mg (three times daily) for acute non-specific lower back pain

open access: yesНеврология, нейропсихиатрия, психосоматика, 2021
Prolonged release tolperisone hydrochloride 450 mg (PRTH 450) is a dosage form that is convenient for patients, since it reduces the frequency of drug administration per day: from three immediate release tablets of 150 mg (TH 150) to one tablet of PRTH ...
V. A. Parfenov   +7 more
doaj  

Different pH-sensitivity patterns of 30 sodium channel inhibitors suggest chemically different pools along the access pathway.

open access: yesFrontiers in Pharmacology, 2015
The major drug binding site of sodium channels is inaccessible from the extracellular side, drug molecules can only access it either from the membrane phase, or from the intracellular aqueous phase.
Alexandra eLazar   +5 more
doaj   +1 more source

Comparative study of therapeutic response to baclofen vs tolperisone in spasticity

open access: yesBiomedicine & Pharmacotherapy, 2017
Spasticity from the upper motor neuron syndrome can result from a variety of conditions affecting the cortex or spinal cord. Some of the more common conditions associated with spasticity include spinal cord injury, cerebral palsy, and post-stroke syndrome. In this study we compared the efficacy and safety of baclofen vs tolperisone in spasticity.
Saurabh, Agarwal   +3 more
openaire   +2 more sources

Compatibility of Tolperisone Hydrochloride and Dantrolene Sodium in Ground Mixture.

open access: yesJapanese Journal of Hospital Pharmacy, 1996
A ground mixture of tolperisone hydrochloride (TH) (Muscalm S®) and dantrolene sodium (DS) (Dantrium®) was prepared for a 4-year-old patient with cerebral paralysis. Seven days later, a change of color from orange to yellow was found. Therefore, we examined the compatibility of TH and DS in the preparation.
HIRAKAWA, MASAAKI   +4 more
openaire   +2 more sources

Chemometrics-Assisted UV Spectrophotometric and RP-HPLC Methods for the Simultaneous Determination of Tolperisone Hydrochloride and Diclofenac Sodium in their Combined Pharmaceutical Formulation

open access: yes, 2013
Chemometrics-assisted UV spectrophotometric and RP-HPLC methods are presented for the simultaneous determination of tolperisone hydrochloride (TOL) and diclofenac sodium (DIC) from their combined pharmaceutical dosage form.
Vijaykumar PARMAR   +2 more
core   +1 more source

ePosters Virtual

open access: yes
European Journal of Neurology, Volume 32, Issue S1, June 2025.
wiley   +1 more source

Home - About - Disclaimer - Privacy